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The ghrelin receptor (GHSR1a) and dopamine recep-
tor-1 (DRD1) are coexpressed in hippocampal neu-
rons, yet ghrelin is undetectable in the hippocampus;
therefore, we sought a function for apo-GHSR1a.
Real-time single-molecule analysis on hippocampal
neurons revealed dimerization between apo-
GHSR1a and DRD1 that is enhanced by DRD1 ago-
nism. In addition, proximity measurements support
formation of preassembled apo-GHSR1a:DRD1:Gaq
heteromeric complexes in hippocampal neurons.
Activation by a DRD1 agonist produced non-canoni-
cal signal transduction via Gaq-PLC-IP3-Ca
2+ at the
expense of canonical DRD1 Gas cAMP signaling to
result in CaMKII activation, glutamate receptor
exocytosis, synaptic reorganization, and expression
of early markers of hippocampal synaptic plasticity.
Remarkably, this pathway is blocked by genetic or
pharmacological inactivation of GHSR1a. In mice,
GHSR1a inactivation inhibits DRD1-mediated hippo-
campal behavior andmemory. Our findings identify a
previously unrecognized mechanism essential for
DRD1 initiation of hippocampal synaptic plasticity
that is dependent on GHSR1a, and independent of
cAMP signaling.INTRODUCTION
G-protein-coupled receptors (GPCRs) belong to a large family of
cell surface receptors that transduce their signal by activating a
trimeric G protein complex (Gabg). Since GPCRs are important
regulators of cell signaling, developing agonists and antagonists
to target GPCRs is a major focus of drug discovery. However,
traditional approaches to identify drug candidates based on
specificity and functional activity in ‘‘artificial’’ cell-based assays
has failed to accurately predict clinical outcomes. GPCRs are
perceived to signal as monomers, but emerging evidence also
implicates signal transduction through homomers and hetero-
mers. Heteromers may play a crucial role in allosteric interac-
tions that occur between protomers to alter signal transduction1176 Cell 163, 1176–1190, November 19, 2015 ª2015 Elsevier Inc.and modify biological function. Therefore, knowing the physio-
logical pathways regulated by GPCR heteromers, homomers,
and monomers in target cells is clinically relevant.
Our research focuses on Class A GPCRs, and in particular the
orphan growth hormone secretagogue receptor (GHSR1a) that
was subsequently deorphanized by the discovery of ghrelin in
stomach extracts (Howard et al., 1996; Kojima et al., 1999; Smith
et al., 1997). We previously showed that GHSR1a forms hetero-
mers with dopamine receptor-2 (DRD2) in hypothalamic neurons
and that signaling through GHSR1a:DRD2 is essential for DRD2
agonist-induced suppression of food intake (Kern et al., 2012).
Paradoxically, despite expression of GHSR1a in the hippo-
campal structures (Guan et al., 1997), ghrelin is undetectable in
the CNS, with the exception of trace amounts in the hypothala-
mus (Cowley et al., 2003; Furness et al., 2011; Grouselle et al.,
2008; Sakata et al., 2009). Based on this observation, we set
out to identify a function for apo-GHSR1a in the hippocampus.
Using immunohistochemistry on brain sections of Ghsr-IRES-
tau-GFP knock-in mice, we identified hippocampal neurons
that coexpress GHSR1a and DRD1 (Jiang et al., 2006). Although
DRD1 is implicated in regulating hippocampal synaptic plasticity
involved in memory and learning, the mechanisms involved are
incompletely understood (Hamilton et al., 2010; Rossato et al.,
2009). We speculated that determining the function of apo-
GHSR1a in DRD1 expressing hippocampal neurons would pro-
vide new insight into these mechanisms. Previously, studies on
dopamine/DRD1 signaling in the hippocampus have focused
mainly on canonical signaling,withDRD1coupling toGas that en-
hances cyclic AMP (cAMP) accumulation and activation of pro-
tein kinase A (PKA) (Abel et al., 1997; Huang and Kandel, 1995).
However, DRD1 signaling through Gaq has also been described
(Jin et al., 2003; Lezcano and Bergson, 2002); nevertheless,
what determinesGaqoverGas signaling hadnot been elucidated.
Here, we shed light on DRD1 signaling in the hippocampus by
illustrating formation of apo-GHSR1a:DRD1 heteromers that by
an allosteric mechanism result in DRD1 coupling to Gaq at the
expense of Gas. Activation of apo-GHSR1a:DRD1 by a DRD1
agonist mobilizes intracellular Ca2+ ([Ca2+]i) and initiates hippo-
campal synaptic plasticity, independent of cAMP signaling. An
essential modulatory role for apo-GHSR1a on hippocampal
DRD1 signaling would not have been recognized previously
because experiments were performed in animals that express
GHSR1a endogenously. By establishing that apo-GHSR1a is
an essential modifier of DRD1 signaling in the hippocampus,
we resolve the conundrum of hippocampal GHSR1a expression
in the absence of endogenous ghrelin, and provide amechanism
for how DRD1 activation of Gaq-signaling in hippocampal neu-
rons is regulated. While it is generally agreed that memory
consolidation involves DRD1-induced PKA and cAMP signaling,
our results support an essential and fundamental role for Gaq-
PLC-Ca2+ signal transduction in initiating this process.
RESULTS
GHSR1a:DRD1 Heteromers in Native Hippocampal
Neurons
Following confirmation of the selectivity of the DRD1 antibody
(Figure S1A), immunohistochemistry on Ghsr-IRES-tauGFP
mouse brain sections revealed highest levels of GHSR1a and
DRD1 coexpression in the Cornu Ammonis region III of hippo-
campus (CA3) and dentate gyrus (DG) of the hippocampal struc-
tures (Figure 1A). Hypothalamic regions also stained for
GHSR1a, but lacked detectable DRD1 staining (Figure 1A).
To test for formation of GHSR1a:DRD1 heteromers in hippo-
campal neurons, we employed confocal fluorescence reso-
nance energy transfer (FRET) microscopy on hippocampal
brain slices. Biotin-ghrelin labeled with FITC-avidin (green)
was used to detect GHSR1a, and a fluorescently labeled
DRD1 antagonist (red-SKF83566) was used for DRD1. We vali-
dated the utility of fluorescently labeled ligands for FRET and
binding specificity of each fluorophore (Figures S1B–S1D).
FRET confocal microscopy and image analysis showed
GHSR1a and DRD1 in close proximity (6.8 ± 0.1 nm) with a
FRET efficiency of 0.51 ± 0.02, consistent with formation of
GHSR1a:DRD1 heteromers (Figure 1B). Parallel incubations
using hippocampal slices from Ghsr/ mice illustrated red-
SKF83566 labeling of DRD1 receptors without green fluores-
cence labeling (Figure 1B).
GPCRs are recruited and dynamically assembled on the cell
membrane (Kasai and Kusumi, 2014). To monitor real-time dy-
namics of DRD1 and GHSR1a interactions in primary hippocam-
pal neuronal cultures, we performed two-color single-molecule
analyses using total-internal reflection fluorescence microscopy
(TIRF-M). Qdot565-avidin-labeled biotinylated-ghrelin was used
to detect GHSR1a, and Qdot655-labeled DRD1 monoclonal
antibody for DRD1. GHSR1a and DRD1 exhibited mobility and
co-localization in the membrane (Figure S1C). Analysis of the
individual trajectories ofGHSR1aandDRD1molecules illustrated
significantly slower diffusion within the complex, rather than
outside the complex (Figures 1C and 1D). Treatment with a
DRD1-specific agonist (SKF81297) increased co-localization
compared to vehicle treatment (312% ± 31.2% versus 100% ±
9%,p<0.001; Figure 1E) andaugmented the number of co-local-
ization events (163.8% ± 17.1% versus 100% ± 8.5%, p < 0.01;
Figure 1E). By measuring diffusion of the individual GHSR1a
molecules, we showed that SKF81297 significantly increased
the confinement of GHSR1a in a complex with DRD1, as indi-
cated by a reduction in the steady state of the mean square
displacement (MSD) curve (p < 0.001; Figure 1F). The diffusion
coefficient of mobile receptors was higher before SKF81297
treatment (0.033 ± 0.009), than after treatment (0.0072 ± 0.002;
p < 0.01; Figure 1F); hence, single-molecule analysis revealedCthat a DRD1 agonist enhances formation of GHSR1a:DRD1 het-
eromeric complexes on mouse hippocampal neurons.
DRD1 Agonist Activation of GHSR1a:DRD1 Induces Ca2+
Transients via Gaq at the Expense of Gas Coupling in
Hippocampal Neurons
Having demonstrated close proximity and dynamic interactions
of GHSR1a and DRD1 in hippocampal neurons, we asked
whether these interactions modified canonical DRD1 signal
transduction. To test for mobilization of [Ca2+]i, we transduced
primary cultures of mouse hippocampal pyramidal neurons
with lentivirus expressing the genetically encoded Ca2+ sensor
GCaMP3. Treatment with SKF81297 dose-dependently induced
rapid Ca2+ transients (EC50 = 50.37 ± 0.12 nM; Figure 2A). Post-
treatment with ghrelin induced Ca2+ transient in the same neu-
rons that responded to SKF81297 (Figure 2A), which confirmed
coexpression of GHSR1a and DRD1. To test for GHSR1a depen-
dence, we compared the effects of SKF81297 in organotypic
hippocampal slices from Ghsr +/+ and Ghsr / mice express-
ing GCaMP3. Ca2+ transients were induced by SKF81297 in sli-
ces from Ghsr +/+ mice, but not in slices from Ghsr / mice;
thus, Ca2+ mobilization is dependent on interactions between
DRD1 and GHSR1a (Figure 2B, p < 0.001). A characteristic
property of GPCR heteromers is the ability of an antagonist
of one protomer to modify signaling of its protomer partner
(Smith and Milligan, 2010). Pretreating organotypic hippo-
campal slices from Ghsr+/+ mice with the GHSR1a neutral
antagonist JMV2959 blocked SKF81297-inducedCa2+mobiliza-
tion (p < 0.05; Figure 2C), which is consistent with modification of
allosteric interactions between GHSR1a and DRD1 in the
GHSR1a:DRD1 heteromeric complex.
We next asked whether SKF81297-induced [Ca2+]i mobiliza-
tion was mediated by DRD1:Gaq coupling through a preassem-
bled GHSR1a:DRD1:Gaq complex. Gaq and DRD1 showed
punctate co-localization in neuritic processes, indicating forma-
tion of signalosomes (Figure 2D). FRET confocal microscopy
showed Gaq and DRD1 in close proximity (5.45 ± 0.2 nm;
FRET efficiency, 0.416 ± 0.06; Figure 2D), consistent with
GHSR1a:DRD1:Gaq preassembly in hippocampal neurons. In
contrast to DRD1:Gaq, the FRET distance (9.98 ± 0.035 nm)
and FRET efficiency (0.005 ± 0.02; Figure 2D) measured for
DRD2 and Gaq in hippocampal neurons is inconsistent with their
close proximity.
In the striatum, DRD2 and DRD1 are reported to form hetero-
mers that couple to Gaq; concomitant agonist activation of
DRD2 and DRD1 mobilized Ca2+, which was blocked by a
DRD2 antagonist (Hasbi et al., 2009). While proximity measure-
ments did not support DRD2:Gaq interactions in hippocampal
neurons (Figure 2D), the possibility remained that DRD1 agonist-
induced [Ca2+]i mobilization was explained by DRD1 coupling
to Gaq in a DRD2:DRD1 complex rather than GHSR1a:DRD1.
To address this possibility, we measured [Ca2+]i release
after treatment with pharmacologic agents: DRD1 agonist,
SKF81297; DRD2 agonist, quinpirole; DRD2 antagonist, raclopr-
ide. Quinpirole neither mobilized, nor enhanced, SKF81297-
induced [Ca2+]i mobilization (Figure 2E), and raclopride did not
attenuate SKF81297-induced Ca2+ release (Figure 2F); thus,
signaling through a DRD2:DRD1:Gaq complex does not explainell 163, 1176–1190, November 19, 2015 ª2015 Elsevier Inc. 1177
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SKF81297-induced Ca2+ release in hippocampal neurons. In
addition, SKF81297did notmobilizeCa2 in hypothalamic neurons
or in striatal neurons (Figure 2G). Further supporting hippocampal
specificity, confocal FRET microscopy showed no evidence of
GHSR1a:DRD1 heteromers in hypothalamic or striatal neurons
(Figure 2H).
To test whether SKF81297 activation of [Ca2+]i release through
GHSR1a:DRD1 was mediated by Phospholipase C (PLC), we
monitored, in real-time, the localization of phosphatidylinositol
4,5-bisphosphate (PIP2). Primary hippocampal neurons from
Ghsr+/+ and Ghsr/ mice were transduced with lentivirus en-
coding the PIP2 biosensor, GFP-PH (Stauffer et al., 1998). In the
basal state, GFP-PH was confined to the plasma membrane,
indicating that the GHSR1a:DRD1 complex was not constitu-
tively active. Treatment with SKF81297 rapidly induced cyto-
plasmic accumulation of GFP-PH in the soma and in neuritic
processes of hippocampal neurons from Ghsr+/+, but not in
neurons from Ghsr/ mice (Figure 3A); thus, translocation of
PIP2 is dependent on GHSR1a. Pretreatment of hippocampal
neurons with the PLC inhibitor U73122 inhibited DRD1 agonist-
induced Ca2+ mobilization, further supporting dependence on
PLC (p < 0.001; Figure 3B). To determine whether Gaq coupling
and PLC activation occurred at the expense of canonical DRD1
Gas coupling, membranes isolated from the hippocampus of
Ghsr+/+ and Ghsr/ mice were treated with SKF81297 or
vehicle, and cAMP production measured. Hippocampal mem-
branes from Ghsr+/+ mice produced markedly less cAMP in
response to SKF81297 compared to those from Ghsr /
mice (Figure 3C). Therefore, the presence of GHSR1a on
the membranes reduces DRD1 coupling to Gas in favor of Gaq,
suggesting an equilibrium between GHSR1a:DRD1 and DRD1:
DRD1 on the hippocampal neuron to allow signaling through
Gaq and Gas, respectively.
DRD1 Agonist-Induced [Ca2+]i Mobilization Correlates
with GHSR1a:DRD1 Heteromer Formation
To further characterize interactions between apo-GHSR1a and
DRD1, and to determine whether GHSR1a heteromerization
and dopamine activation of non-canonical DRD1 signaling is
conserved across species, we expressed human GHSR1a and
DRD1 in the human embryonic kidney (HEK293) cell line. We
monitored heteromerization by time-resolved (Tr)-FRET using
GHSR1a and DRD1 with a SNAP- or CLIP- tagged N terminus,
using methods described previously (Kern et al., 2012). Tr-FRETFigure 1. Co-expression of GHSR1a and DRD1 in Mouse Hippocamp
Microscopy and TIRF-M
(A) Brain sections from Ghsr-IRES-tauGFP mice stained for DRD1 (red) and GHS
and DRD1 (ArcN/ME, arcuate nucleus and median eminence; LH, lateral hypotha
regions. Scale bar, 10 mm.
(B) Confocal microscopic FRET analysis of GHSR1a:DRD1 heteromers in DG, Sc
(C and D) Quantification of trajectories of GHSR1a and DRD1 in neuron process
diffusion coefficients of GHSR1a trajectories in and outside a complex with DR
GHSR1a (D; ntrajectories = 111).
(E) Two-color single-molecule TIRF-M images of interactions of GHSR1a with DR
(1 mM) treatment: GHSR1a (red), DRD1 (green). Kymographs images of co-localiz
localization and counts of co-localization.
(F) Individual GHSR1a trajectories by TIRF-M before and after SKF81297 treatm
Data represent the mean ± SEM of at least three experiments (*p < 0.05 versus c
Creceptor titration assays and competition assays supported the
formation of GHSR1a and DRD1 homomers and heteromers on
the plasma membrane (Figures S2A and S2B). As additional
proof of heteromer formation, bioluminescence resonance
energy transfer (BRET) saturation, type-2 BRET, and micro-
scopic BRET assays were conducted. The results ruled out
random stochastic interactions between apo-GHSR1a and
DRD1 and confirmed formation of GHSR1a:DRD1 heteromers
(Figures S2C–S2E).
We employed HEK293-AEQ cells that stably express the
bioluminescence Ca2+ sensor aequorin to monitor [Ca2+]i mobi-
lization. Dopamine and SKF81297 dose-dependently induced
Ca2+ mobilization with dependence on apo-GHSR1a, which
was blocked by the DRD1 antagonist, SCH23390, but not by
the DRD2 antagonist, raclopride (Figures S3A–S3C). In control
experiments, Ca2+ release was not detected when GHSR1a or
DRD1 were coexpressed with other Gas- or Gaq-coupled
GPCRs (Figure S3D), which was consistent with their failure to
form heteromers (Figure S2B). Collectively, these results show
that dopamine-induced [Ca2+]i mobilization correlates with
GHSR1a:DRD1 heteromer formation rather than cross-talk
between Gaq and Gas signaling. To quantify the correlation
between GHSR1a:DRD1 formation and [Ca2+]i release, we
constructed GHSR1a fusion proteins containing inducible ho-
modimerization domains at the C terminus (GHSR1a-Hom).
The cross linking agent, B/B, dose-dependently reduced dopa-
mine-induced [Ca2+]i mobilization by 40%–50% in HEK293-AEQ
cells expressing GHSR1a-Hom + DRD1 compared to cells ex-
pressing GHSR1a + DRD1 (Figures 4A and 4B). B/B itself did
not attenuate Ca2+ release or cell surface expression of either
GHSR1a-Hom or DRD1 (Figures 4C and Figures S3E–S3G).
TIRF-M analyses showed B/B treatment enhanced GHSR1a-
Hom homodimerization by 50%, thereby reducing the con-
centration of GHSR1a-Hom monomers available for forming
heteromers (Figure S3H). The resulting reduction in the concen-
tration of GHSR1a-Hom:DRD1 heteromers correlated with
dopamine-induced [Ca2+]i mobilization (Figure 4B).
Additional experiments tested whether dopamine-induced
Ca2+ release involved cross-talk between Gas and Gaq within
the heteromeric complex or involved GHSR1a constitutive activ-
ity. We found that dopamine-induced [Ca2+]i mobilization by
GHSR1a:DRD1was not dependent on signaling through Gas,
AC-PKA, Gai/o-Gbg, or PKC (Figures S4A–S4E). Coexpressing
DRD1 with GHSR1a mutants lacking constitutive activityal Neurons and Heteromer Formation Measured by FRET Confocal
R1a (green). White arrows indicate individual neurons co-expressing GHSR1a
lamus). Coexpression of GHSR1a and DRD1: 46%, DG; 17%, CA3; 10%, CA1
ale bar, 5 mm.
es: GHSR1a (red), DRD1 (green), overlapping (yellow). MSD versus time, and
D1(C; ntrajectories = 236), and DRD1 trajectories in and outside a complex with
D1 in dendritic processes of hippocampal neurons before and after SKF81297
ation (yellow); quantitative analysis of the interactions measured by area of co-
ent: MSD versus time, diffusion coefficients.
ontrol; **p < 0.01 versus control; ***p < 0.001 versus control).
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Figure 3. In Hippocampal Neurons, GHSR1a Modifies DRD1 Canonical Signaling to Induce [Ca2+]i Release via Gaq at the Expense of Gas
Coupling
(A) SKF81297 (10 mM) induces translocation of the PLC sensor (GFP-PH) to cytoplasm in neurons ofGhsr+/+mice (upper row), but not neurons ofGhsr/mice
(lower row); Scale bar, 5 mm.
(B) PLC inhibitor (U73122, 10 mM) blocks SKF81297 (10 mM)-induced [Ca2+]i release in hippocampal neurons.
(C) Dose-dependent effects of SKF81297 treatment on cAMP accumulation is lower in hippocampal membranes from Ghsr+/+ (-) than in membranes from
Ghsr/ (C) mice.
Data represent the mean ± SEM of at least three independent experiments (**p < 0.01 versus control; ***p < 0.001 versus control).(F279L and A204E) resulted in dopamine-induced Ca2+ release
(Figure S4F); hence, non-canonical DRD1 signaling is indepen-
dent of GHSR1a constitutive activity. The observed 30%–40%
reduction in the Ca2+ response is likely explained by the lower
affinity of the mutants for forming heteromers with DRD1
(Figure S4G).
To test for formation of an apo-GHSR1a:DRD1:Gaq complex
in HEK293 cells, we combined bimolecular fluorescence
complementation (BiFC) and BRET analysis (Gale´s et al.,
2006). Co-expression of split YFP-tagged GHSR1a and DRD1
(GHSR1a-YFP-C and DRD1-YFP-N) produced YFP fluores-Figure 2. In Hippocampal Neurons, DRD1 Agonist-Induced [Ca2+]i Mob
(A) SKF81297 (10 mM, upper row) produced a transient Ca2+ response in hippoca
(100 nM, lower row). SKF81297 induced dose-dependent [Ca2+]i release (right).
(B) SKF81297-induced [Ca2+]i mobilization in hippocampal organotypic slices fro
(C) JMV2959 (10 mM) inhibits SKF81297 (10 mM) induced [Ca2+]i mobilization in h
(D) Hippocampal neurons treated with vehicle (upper) or JMV2959 (middle); Gaq (g
(red), Gaq (green); quantitative analysis of FRET efficiency and FRET distance (ri
(E and F) [Ca2+]i mobilization in hippocampal organotypic slices in the presence
(10 mM) (E); or SKF81297 (10 mM) and SKF81297 (10 mM) + Raclopride (10 mM) (F
(G) SKF81297-induced (10 mM) [Ca2+]i mobilization in neurons from hippocampu
(H) FRET confocal microscopy images on organotypic brain slices from hippoca
control. GHSR1a (green), DRD1 (red); Scale bar, 5 mm.
Data represent the mean ± SEM of at least three independent experiments in du
Ccence localized on the plasma membrane, confirming formation
of GHSR1a:DRD1 heteromers (Figure S5A). Expression of Gaq-
Rluc8 with the split YFP-tagged GHSR1a and DRD1 produced
a robust BRET signal, consistent with Gaq in a preassembled
complex with GHSR1a:DRD1, which was not observed in
control experiments (Gaq-Rluc coexpressed with DRD1-YFP-
N + DRD1-YFP-C or empty vector) (Figure S5A). Agonist treat-
ment markedly reduced the BRET signal associated with the
GHSR1a-YFP-C:DRD1-YFP-N:Gaq-Rluc8 complex, illustrating
agonist-induced dissociation of Gaq (Figure S5A). To assess
direct coupling to the Gaqbg trimer, Gaq-Rluc8 and splitilization Is Dependent on GHSR1a, but Not on DRD2
mpal neurons; after removing SKF81297 the same cells responded to ghrelin
Scale bar, 10 mm.
m Ghsr+/+ and Ghsr / mice (left).
ippocampal organotypic slices.
reen) and DRD1 (red) images analyzed by FRETmicroscopy. Lower row: DRD2
ght). Scale bar, 10 mm.
of SKF81297 (10 mM), SKF81297 (10 mM) + Quinpirole (10 mM), and Quinpirole
).
s, hypothalamus, and striatum (left).
mpus, hypothalamus, and striatum of Ghsr+/+ mice; slices from Ghsr/ as
plicate (*p < 0.05 versus control; ***p < 0.001 versus control).
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Figure 4. Dopamine-Induced [Ca2+]i Mobilization Correlates with Formation of GHSR1a:DRD1 Heteromers
(A) Dopamine-induced [Ca2+]i mobilization measured in HEK-AEQ cells expressing DRD1 with either GHSR1a (-) or GHSR1a-Hom (:) preincubated with
increasing concentrations of homodimerization inducer (B/B).
(B and C) Dose-dependent dopamine-induced [Ca2+]i release in the absence or presence of B/B in cells coexpressing GHSR1a-Hom and DRD1 (B) or in cells
coexpressing GHSR1a and DRD1 (C).
Data represent the mean ± SEM of at least three independent experiments (*p < 0.05 versus control; **p < 0.01 versus control; ***p < 0.001 versus control).Venus-Gb1 and -Gg2 proteins were coexpressed with GHSR1a
and DRD1 (Figure S5B). The BRET signal was attenuated by
SKF81297 treatment (p < 0.001; Figure S5B, middle panel),
consistent with DRD1 pre-coupling to Gaq and agonist-
induced dissociation of the heterotrimeric G protein complex.
Pretreatment with JMV2959 dose-dependently inhibited the
SKF81297-induced decrease in BRET (IC50 = 477 ± 45 nM; Fig-
ure S5B, right panel); hence, GHSR1a is intimately involved in
DRD1:Gaq coupling. Dopamine-induced cAMP accumulation
was reduced when DRD1 was expressed with GHSR1a, indi-
cating GHSR1a promotes DRD1 coupling to Gaq at the expense
of Gas coupling (Figure S5C).
To determine whether GHSR1a antagonists inhibit dopa-
mine-induced Ca2+ mobilization by interfering with allosteric
interactions between GHSR1a and DRD1, three structurally
distinct GHSR1a neutral antagonists (JMV2959, JMV3002,
and BIM-28163) equipotent in inhibiting ghrelin activation of
GHSR1a were tested (Figure S5D). The antagonists had no ef-
fect on DRD1-induced cAMP accumulation (Figure S5E).
JMV2959 was a full antagonist of dopamine-induced [Ca2+]i
release, while JMV3002 and BIM were partial antagonists
(Figure S5F). BRET titration employing Nluc-GHSR1a and
SNAP-DRD1 in the presence or absence of each GHSR1a
antagonist was performed. JMV2959 did not affect the
BRET50, but significantly changed the BRETmax (BRETmax con-
trol, 0.0038 ± 0.0008, and BRETmax JMV2959, 0.0017 ±
0.0005; p < 0.05; Figure S5G), indicating JMV2959 modifies1182 Cell 163, 1176–1190, November 19, 2015 ª2015 Elsevier Inc.allosteric interactions between GHSR1a and DRD1 (Hamdan
et al., 2006). Furthermore, in agreement with their inhibitory ef-
fects on dopamine-induced [Ca2+]i mobilization (Figure S5F),
JMV3002 and BIM-28163 were less active than JMV2959 in
the BRET assay (Figure S5H). These results support an
allosteric mechanism for GHSR1a dependent non-canonical
DRD1 signaling.
Although the collective data supported formation of a preas-
sembled apo-GHSR1a:DRD1:Gaq complex, and indicated
dopamine-induced [Ca2+]i release is mediated via DRD1:Gaq,
an alternative explanation is that dopamine binding to DRD1
modifies the conformation of DRD1 that in turn allosterically in-
duces apo-GHSR1a:Gaq coupling. To test this possibility we
generated a GHSR1a mutant where residues in the third
intracellular loop necessary for Gaq coupling were inactivated
by alanine substitution. A(237-244)-GHSR1a did not couple
to Gaq and was refractory to activation by ghrelin, and ELISA as-
says confirmed expression on the cell surface (Figures S6A–
S6D); Tr-FRET assays illustrated heteromer formation with
DRD1 (Figures S6E and S6F). Despite the inability of A(237-
244)-GHSR1a to couple to Gaq, dopamine treatment of A(237-
244)-GHSR1a:DRD1 heteromers dose-dependently induced
Ca2+ transients, confirming direct coupling of DRD1 to Gaq.
However, the amplitude of the Ca2+ response was 50% that
of WT-GHSR1a:DRD1 (Figure S6G), suggesting that signaling
via WT-GHSR1a:DRD1 heteromers is mediated by a combina-
tion of DRD1:Gaq and apo-GHSR1a:Gaq coupling (Figure S6H).
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Figure 5. DRD1 Agonist-Induced CaMKII Activation in Hippocampal Neurons Is Dependent upon GHSR1a:DRD1 Interactions
(A) Hippocampal slices from Ghsr+/+ andGhsr/mice treated with SKF81297 (10 mM) ± JMV2959 illustrating phosphorylation of CaMKII (left) and quantitative
analysis (right panels).
(B andC) Representative TIRF-M images (B) and time lapse plot (C; left graph) with quantitative analysis (C; right graph) from neurons ofGhsr+/+ orGhsr/mice
expressing GFP-CaMKIIa following treatment with SKF81297 ± JMV2959.
Data represent the mean ± SEM of at least three independent experiments: **p < 0.01 versus control; ***p < 0.001 versus control.DRD1 Agonist-Induced Activation of Synaptic Plasticity
Markers in Hippocampal Neurons Is Dependent on
apo-GHSR1a
Phosphorylation of CaMKII is involved in activation of synaptic
plasticity and is regulated by Ca2+; therefore, we asked if
apo-GHSR1a was essential for DRD1 agonist activation of
CaMKII. When we treated organotypic hippocampal slices
fromGhsr+/+mice with SKF81297, the number of pCaMKII-pos-
itive neurons was markedly enhanced (44.56% ± 4.3% versus
vehicle 11.94% ± 4.9%, p < 0.001; Figure 5A), as was the inten-
sity of staining (37.8% ± 2.2% versus vehicle 5.4% ± 1%,
p < 0.001; Figure 5A). Pretreatment with JMV2959 inhibited the
effect of SKF81297. Also, hippocampal slices from Ghsr/
mice were refractory to SKF81297-induced CaMKII phosphory-
lation (Figure 5A), further illustrating dependence on GHSR1a.
Synaptic activity results in pCaMKII translocation from the den-
dritic cytoplasm to the synapse. Time-lapse imaging of hippo-
campal neurons from Ghsr+/+ mice expressing GFP-CaMKIIa
cDNA showed that SKF81297-induced accumulation of GFP-
CaMKII at synapses (Figure 5B); this phenomenon wasmarkedly
attenuated in hippocampal neurons fromGhsr/mice (100% ±C30.5% versus 34.78% ± 4.8%, p < 0.01; Figure 5C). Pretreating
Ghsr+/+ neurons with JMV2959 inhibited SKF81297-induced
CaMKII translocation (20% ± 4.9%, p < 0.01; Figure 5C). Hence,
DRD1 agonist-mediated CaMKII activation and translocation is
dependent on GHSR1a. Synaptic localization of translocated
GFP-CaMKIIa was confirmed using the post-synaptic marker
PSD95-DsRed (Figure S7A).
Synaptic plasticity and hippocampal memory formation are
regulated by glutamate receptors. Phosphorylation of the GluR1
subunit of AMPAR at Ser831 by CaMKII is critical for AMPAR
function and trafficking (Barria et al., 1997). SKF81297 increased
Ser831 phosphorylation in organotypic hippocampal slices
from Ghsr+/+mice that was inhibited by pretreatment with either
the CaMKII inhibitor (KN93), or JMV2959 (p < 0.001; Figure 6A). In
Ghsr/ hippocampal slices, SKF81297 activation of AMPAR
was markedly lower, illustrating dependence on GHSR1a (p <
0.001; Figure 6A). To determine whether exocytosis of gluta-
mate receptors in hippocampal neurons was dependent on
GHSR1a:DRD1 signaling, we employed pHluorin-tagged NR1
and GluR1 subunits (SEP-NR1 and SEP-GluR1). When
hippocampal neurons from Ghsr+/+ expressing SEP-NR1 orell 163, 1176–1190, November 19, 2015 ª2015 Elsevier Inc. 1183
SEP-GluR1 were treated with SKF81297, significant increases in
fluorescence intensity were observed, indicating exocytosis of
glutamate receptors at synapses (Figures 6B and 6C); similarly
treated neurons from Ghsr/ mice were unresponsive. Pre-
treatment of Ghsr+/+ mouse neurons with JMV2959 inhibited
SKF81297-induced exocytosis of NR1 and GluR1 (p < 0.001;
Figures 6B and 6C), confirming that DRD1 agonist-induced
exocytosis of glutamate receptors is dependent on interactions
between GHSR1a and DRD1. Lifeact was used to measure actin
accumulation (Riedl et al., 2008): SKF81297 treatment enhanced
actin accumulation in hippocampal neurons, which was sig-
nificantly reduced by JMV2959 pretreatment, indicating that
SKF81297-mediated synaptic reorganization is dependent on
GHSR1a (p < 0.001; Figure 6D).
If DRD1 agonist activation of neuronal plasticity in hippocam-
pal neurons is dependent on GHSR1a, transcription of genes
involved in initiation of neuronal plasticity should also be depen-
dent on GHSR1a. Neuronal activity frequently correlates with
signaling pathways that induce phosphorylation of ribosomal
protein S6. We applied ribosome capture to enrich for mRNAs
expressed in response to SKF81297 activation of hippocampal
neurons and to enhance the dynamic range of enrichment em-
ployed pS6-244 selective immunoprecipitation (Knight et al.,
2012). SKF81297 markedly increased pS6-244 immunofluores-
cent cells in hippocampal slices from Ghsr+/+ mice relative to
vehicle treatment (52.43% ± 7% versus, 8.84% ± 1.18%
p < 0.001, Figures 6E and 6F); fluorescence intensity was also
enhanced (100% ± 6.85% versus 9.57% ± 1%, p < 0.001, Fig-
ures 6E and 6G). JMV2959 pretreatment markedly lowered
SKF81297-induced S6-244 phosphorylation in Ghsr+/+slices;
slices from Ghsr/mice were refractory to SKF81297 treat-
ment (p < 0.001; Figures 6E–6G). Treatment with 2-aminoethox-
ydiphenyl borate (2-APB) inhibited SKF81297-induced S6-244
phosphorylation (Figure S7B), indicating activation is dependent
on release of [Ca2+]i. Analysis of mRNA eluted from immunopre-
cipitated pS6-244-positive ribosomes from SKF81297-treated
Ghsr+/+ hippocampal slices showed enriched expression of
genes associated with initiation of synaptic plasticity: Nr4a1,
Nr4a2, Nr4a3, Ntrk2, Arc, and Zif268 (Figure 6H). Pretreatment
with JMV2959 inhibited SKF81297-induced expression of these
genes (Figure 6H). In addition, enhanced expression of these
genes was not observed when slices from Ghsr/ mice were
treated with SKF81297 (Figure 6H). These data illustrate that
DRD1-induced initiation of hippocampal synaptic plasticity is
GHSR1a-dependent and further support an important functional
role for apo-GHSR1a:DRD1 heteromers.
Dependence on Hippocampal GHSR1a for DRD1
Regulated Behaviors
We next examined the biological relevance of apo-GHSR1a-
dependent DRD1 signaling in the hippocampus by measuring
DRD1 agonist-induced behavioral responses when GHSR1a
was either genetically or pharmacologically inactivated. Pre-
pulse inhibition (PPI) is ameasure of sensorimotor gating that de-
termines how well an animal can integrate and inhibit sensory
information (Mansbach et al., 1988). Although the nucleus ac-
cumbens was once viewed as the primary structure involved in
dopamine-induced interference with PPI, subsequent studies1184 Cell 163, 1176–1190, November 19, 2015 ª2015 Elsevier Inc.with DRD1 selective agonists and antagonists applied systemi-
cally or directly to the hippocampus showed that disruption of
PPI involved DRD1 agonist action on the dorsal hippocampus
(Ellenbroek et al., 2002). Given these findings, we tested whether
DRD1-induced interference with PPI was dependent upon
GHSR1a by comparing PPI in DRD1agonist-treated Ghsr+/+
and Ghsr/ mice. In the absence of the DRD1 agonist, both
genotypes produced identical PPI responses (Figure 7A).
Whenmicewere injectedwith the DRD1 agonist, PPI was disrup-
ted in Ghsr+/+mice, but not in Ghsr/mice (Figure 7A); there-
fore, DRD1-induced interference with PPI is dependent upon
GHSR1a.
Coexpression of GHSR1a and DRD1 is most abundant in the
DG of the hippocampal structures and neuronal activity that in-
fluences synaptic potentiation and memory is propagated
through the DG. Our ex vivo experiments showed that DRD1
agonist induced biochemical changes associated with initiation
of hippocampal synaptic plasticity are blocked by JMV2959.
Therefore, we selected behavioral tests of memory associated
with activation of synaptic plasticity that is enhanced by hippo-
campal DRD1 agonism and asked if enhanced performance
was inhibited by JMV2959.
DRD1 signaling in the DG is implicated in contextual fear con-
ditioning (CFC) (Sarin˜ana et al., 2014), and agonist activation of
DRD1 in the dorsal hippocampus results in consolidation of
CFC extinction (Fiorenza et al., 2012). Therefore, we asked
whether DRD1-mediated extinction of CFC was dependent on
GHSR1a. Mice were trained in the CFC apparatus and then
placed in their home cage. The mice were returned to the appa-
ratus 24 hr later and Extinction-1 phase (20 min) was measured
(Figure 7B). The freezing response of the mice declined as a
function of time (compare 0–3 min with 17–20 min, Figure 7B).
Immediately after Extinction-1, mice received intra-DG infusions
of vehicle, SKF81297, SKF81297 + JMV2959, or JMV2959 alone
(Figure S7C). Twenty-four hours later Extinction-2 was per-
formed. Mice treated with SKF81297 exhibited a significant
decrease in freezing behavior compared to the vehicle-treated
group, consistent with DRD1 agonist-induced consolidation
of extinction memory (Figure 7B). In mice coadministered
JMV2959 and SKF81297, the freezing response was equal to
that in vehicle-treated controls; hence, JMV2959 inhibits
SKF81297-induced consolidation of extinction (Figure 7B), illus-
trating dependence on allosteric interactions between GHSR1a
and DRD1.
To determine if allosteric interactions between GHSR1a and
DRD1 in the DG are important for DRD1-mediated enhancement
of working memory, we utilized the T-maze alternation test
(Deacon and Rawlins, 2006). Alternation is viewed as an excel-
lent test for determining hippocampal function in mice and for
mice is a more robust test than the Morris water maze (Deacon
and Rawlins, 2006). Mice were trained to learn a food pellet is
placed in alternate arms of the T-maze. Training is considered
complete when the mice make the correct choice 75% of the
time (Figure 7C). On the test day,mice received intra-DG infusion
of vehicle, SKF81297, SKF81297 + JMV2959, or JMV2959 alone.
Themice were retested without delay and then after a 90 s delay.
In contrast to vehicle infusion, mice infused with SKF81297
continued to make 75% correct choices following the 90 s delay,
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consistent with enhanced working memory (p < 0.05; Figure 7C).
Coadministration of JMV2959 with SKF81297 blocked the bene-
ficial effect of SKF81297 on working memory (p < 0.05; Fig-
ure 7C). Infusion of JMV2959 alone had no effect on immediate
performance, but performance was impaired following a 90 s
delay and inferior to that of vehicle infused mice (Figure 7C), indi-
cating that JMV2959 inhibited endogenous dopamine/DRD1
signaling. These results provide additional evidence for the bio-
logical significance of allosteric interactions between GHSR1a
and DRD1 in the DG.
DISCUSSION
Our objective was to determine the functional role of the ghre-
lin receptor (GHSR1a) in the hippocampus where endogenous
ghrelin is undetectable (Banks et al., 2002; Furness et al., 2011;
Grouselle et al., 2008; Sakata et al., 2009). The absence of
endogenous ghrelin in the mouse brain is supported by phar-
macokinetic studies following i.v. administration of mouse
131I-ghrelin (Banks et al., 2002). When administered systemi-
cally to mice, ghrelin binding in the CNS is confined to hypo-
thalamic neurons (Schaeffer et al., 2013); c-Fos is activated
in the arcuate nucleus, paraventricular nucleus (PVN), and
lateral hypothalamus (LH) (Pirnik et al., 2011). Infusing ghrelin
directly into the LH releases orexin, and orexin acts on ventral
tegmental area (VTA) neurons causing dopamine release (Cone
et al., 2014). Dopaminergic neurons in the VTA innervate
the hippocampus, implicating a VTA-hippocampal loop that
regulates hippocampal plasticity (Gasbarri et al., 1994; Lisman
and Grace, 2005; Swanson, 1982). These data argue that
the effects of pharmacological doses of ghrelin on the hippo-
campus that have been proposed to be a direct effect on
synaptic plasticity are instead indirect and mediated by
dopamine. Physiologically, the absence of endogenous ghrelin
in the hippocampus allows apo-GHSR1a to modify dopamine
signaling locally through apo-GHSR1a:DRD1 heteromer forma-
tion, which initiates synaptic plasticity through DRD1 coupling
to Gaq.
Intriguingly, dynamic studies in hippocampal neurons show
DRD1 agonism enhances interactions between DRD1 and
GHSR1a. DRD1 agonism also regulates the dynamics of DRD1
and N-methyl-D-aspartate (NMDA) receptor interactions in syn-
apses (Ladepeche et al., 2013). Studies in WT rodents that
express GHSR1a endogenously demonstrated that DRD1 regu-Figure 6. DRD1 Activation of Neuronal Plasticity Markers in Hippocam
(A) Phosphorylation of AMPAR (p831-GluR1) in organotypic hippocampal slices fr
SKF81297 (10 mM), and CaMKII inhibitor (KN93) + SKF81297 (10 mM); control, sl
analyses (right). Scale bar, 10 mm.
(B and C) SKF81297-induced exocytosis of NR1or GluR1 detected by TIRF-M. Hi
or SEP-GluR1 (C) treated with SKF81297 (10 mM) and ± JMV2959 (10 mM); represe
analysis (right).
(D) Representative images of hippocampal neuronal processes expressing mCh
(left); time lapse plot (middle) and quantitative analysis (right); scale bar, 20 mm.
(E) Activation of hippocampal neurons in organotypic slices measured by pS6 im
(F and G) Quantitative analysis according to number of pS6-positive cells (F) or t
(H) Gene expression of early markers associatedwith initiation of neuronal plasticit
JMV2959 (10 mM).
Data represent the mean ± SEM of at least three independent experiments (*p <
1186 Cell 163, 1176–1190, November 19, 2015 ª2015 Elsevier Inc.lates synaptic plasticity and long-term potentiation (LTP) by
enhancing NMDA responses. DRD1 and NMDA receptor
(NMDAR) interact through intracellular signaling involving heter-
omerization (Cepeda and Levine, 2006). DRD1 agonism
enhances NMDA responses in the hippocampus, cortex, and
striatum through signaling cascades involving release of [Ca2+]i
and activation of CaMKII, PKC, and PKA (Cepeda and Levine,
2006). Our results support this mechanism and further suggest
dopamine activation of GHSR1a:DRD1 as an initiation step for
enhancing NMDA currents. Indeed, dependence on GHSR1a
for DRD1-induced exocytosis of NR1 supports GHSR1a:DRD1
heteromers as enhancers of the NMDA response. In hippocam-
pal neurons, dissociation of DRD1:NR1 complexes upon DRD1
activation facilitates CaMKII activity (Nai et al., 2010), which
is consistent with the idea that dissociation of the DRD1:NR1
heteromer could shift stoichiometry toward an increase in
GHSR1a:DRD1 heteromers, and as a consequence increase
dopamine activation of CaMKII as observed here. Clearly, addi-
tional studies are needed to elucidate the role of GHSR1a:DRD1
in DRD1 regulation of NMDA signaling and relationships to
DRD1:NR1 complex formation.
Elucidating the mechanism of signaling through GHSR1a:
DRD1 hippocampal neurons revealed preassembly of an apo-
GHSR1a:DRD1:Gaq macro-complex. Proximity measurements
and biochemical studies implicate a mechanism where dopa-
mine-induced [Ca2+]i mobilization is mediated by direct coupling
of DRD1 to Gaq. DRD1:Gaq couplingwas confirmed by substitut-
ing WT-GHSR1a for a GHSR1a mutant where sites for Gaq
coupling were inactivated and showing that dopamine activation
of themutant-GHSR1a:DRD1heteromermobilized [Ca2+]i.Never-
theless, compared to WT-GHSR1a:DRD1 the magnitude of
dopamine-induced Ca2+ release was reduced by 50%, sug-
gesting that with WT-GHSR1a:DRD1, both DRD1:Gaq and apo-
GHSR1a:Gaq coupling was involved. What is the stoichiometry?
In lipid nanodiscs, apo-GHSR1a homomers assemble asymmet-
rically with only one protomer actively coupling to Gaq, while the
other protomer is inactive, and in the case of an apo-GHSR1ahet-
eromer, apo-GHSR1a is not actively coupled to Gaq (Mary et al.,
2013). Based on these findings, we speculate that dopamine-
induced [Ca2+]i release is mediated through an asymmetric
heterotetramer (Gaq:GHSR1a:DRD1:GHSR1a:DRD1:Gaq) where
asymmetry allows just one GHSR1a and one DRD1 molecule to
actively couple to Gaq. Gaq coupling and signaling through
PLC is fundamentally important for DRD1 agonist activation ofpal Neurons Is Dependent on GHSR1a:DRD1 Interactions
om Ghsr+/+mice treated with vehicle, SKF81297 (10 mM), JMV2959 (10 mM) +
ices from Ghsr/mice treated with SKF81297 (10 mM) (left); and quantitative
ppocampal neurons fromGhsr+/+ andGhsr/mice expressing SEP-NR1 (B)
ntative images before and after treatment (left); time lapse plot and quantitative
erry-Lifeact, following treatment with SKF81297 (10 mM) ± JMV2959 (10 mM)
munofluorescence (red); nuclei (blue); scale bar, 10 mm.
o pS6 immunofluorescence intensity (G).
y in hippocampal organotypic slices treatedwith vehicle or SKF81297 (10 mM) ±
0.05 versus control; **p < 0.01 versus control; ***p < 0.001 versus control).
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Ca2+ transients and induction of hippocampal synaptic plasticity.
WhenGHSR1a is inactivated,DRD1couples toGas andDRD1ag-
onism augments cAMP accumulation, but synaptic plasticity is
not initiated. We conclude that Gaq coupling via GHSR1a:DRD1
is essential for initiating synaptic plasticity and priming hippo-
campal neurons for subsequent events involving cAMP signaling
and protein synthesis-dependent long-term memory formation
(Abel et al., 1997). Do Gaq andGas sequentially and/or synergisti-
cally regulate downstream pathways that lead to memory
formation? By dissociating DRD1-induced Gaq-PLC from Gas-
PKA signaling, we provide a strategy for dissecting these
mechanisms.
Since GHSR1a:DRD1 heteromers are abundantly expressed
in the DG, the gateway for regulating hippocampal function,
we askedwhether dependence on GHSR1a for activating hippo-
campal synaptic plasticity ex vivo translates to performance
in vivo. In the DG, contextual memory is dependent on DRD1
(Sarin˜ana et al., 2014). We showed that direct infusion of a
DRD1 agonist into the DG of WT mice augments extinction of
CFC, and extinction was blocked by co-infusion of the GHSR1a
antagonist JMV2959. Similarly, DRD1 agonist infusion into the
DG improved working memory that was also blocked by
JMV2959 coinfusion. The results of these behavioral tests
show that DRD1 agonist-induced behaviors are dependent on
interactions between DRD1 and GHSR1a in the DG, confirming
the biological relevance of conclusions derived from ex vivo ex-
periments in hippocampal neurons.
In the dorsal hippocampus, DRD1 plays a role in integrating
and filtering sensory information (Ellenbroek et al., 2002). Impair-
ments in this process have been linked to neuropsychiatric dis-
orders, which can be assessed in rodents and humans by
measuring PPI of the acoustic startle response. Peripheral
administration of a DRD1 agonist to WT mice caused disruption
of PPI, but Ghsr-null mice were resistant. Hence, by selectively
blocking dopamine signaling in GHSR1a:DRD1 expressing
neurons, GHSR1a antagonists may have utility in treating psy-
choses, such as schizophrenia. As a further illustration of depen-
dence on GHSR1a for sensorimotor gating, a recent report
showed that disruption of PPI in rats by the noncompetitive in-
hibitor of the NMDA receptor phencyclidine was blocked by
JMV2959 (Engel et al., 2015).
In conclusion, we show apo-GHSR1a is fundamentally impor-
tant for dopamine/DRD1-induced initiation of hippocampal
synaptic plasticity and formation of hippocampal memory.
All previously reported studies that elucidated mechanisms
of dopamine regulation of hippocampal function were con-
ducted in rodents expressing GHSR1a endogenously; therefore,
the critical role of apo-GHSR1a would have been over-
looked. The results we describe—combined with conclusions
from our previous work showing a functional role for apo-Figure 7. DRD1-Agonist Specific Behaviors Dependent on GHSR1a:DR
(A)Ghsr +/+ andGhsr/mice exhibit a normal PPI response in absence of DRD1
Ghsr / mice are resistant (right) (n = 8–12 animals per group).
(B) Bilateral infusion of SKF81297 (SKF) into the DG induces extinction of CFC th
(C) Alternating T-maze test of working memory. Bilateral infusion of SKF81297 (S
JMV2959 (JMV); (9–10 animals/group).
Data represent the mean ± SEM (*p < 0.05 versus control).
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(Kern et al., 2012)—illustrate a previously unrecognized, but
critical role for apo-GHSR1a as a modulator of dopamine
signaling. Of significance toward CNS drug discovery, the
GHSR1a antagonists tested allosterically inhibit dopamine-
induced Ca2+ mobilization through apo-GHSR1a:DRD1. Based
on this mechanism, different structural classes of GHSR1a an-
tagonists have the potential to enhance, rather than inhibit,
dopamine signaling. This concept has profound therapeutic im-
plications because it allows selective pharmacological fine-tun-
ing of dopamine signaling in subsets of neurons that express
GHSR1a:DRD2 or GHSR1a:DRD1, without affecting neurons ex-
pressing DRD2 or DRD1 alone. Broader application of this
concept involves identifying neutral molecules that target the
unique structural interface formed by GPCR protomers in a
GPCR heteromeric complex. Finally, our results reinforce the
importance of knowing the GPCR composition of the clinically
important native target cell when developing pharmacologic
agents, because the presence or absence of a potential GPCR
protomer partner markedly affects biological responses. Indeed,
antagonists, agonists, and biased agonists for GPCRs have
the potential to modify signal transduction, depending on
whether signaling proceeds via GPCR monomers, homomers,
or heteromers.
EXPERIMENTAL PROCEDURES
Hippocampal Primary Cell Isolation and Organotypic Brain Slice
Preparation
Primary cells were isolated from hippocampi of P1–P3mice. Organotypic brain
slices (300 mm) were prepared from hippocampi of post-natal day 5–7 mice
and cultured on membrane inserts (see Supplemental Experimental Proce-
dures for more details).
Intracellular Ca2+ Mobilization, Inducible Homomerization, and
cAMP Accumulation
In hippocampal primary cells and organotypic brain slices, Ca2+ was detected
usingGCaMP3. For the inducible homomerization assay, Ca2+was detected in
HEK-AEQ cells (Kern et al., 2012) in the absence or presence of homodimerizer
(B/B; Clontech). cAMP production in hippocampal brain membranes was
measured with LANCE Ultra cAMP assay (Perkin Elmer) (see Supplemental
Experimental Procedures for more details).
Microscopic TIRF Measurements
TIRF imaging was performed using Olympus FluoView 1000 equipped with
commercially available objective-based TIRF (Olympus); see Supplemental
Experimental Procedures for more details.
Microscopic FRET Analysis of Hippocampal Neurons and Brain
Slices
Gaq proximity andGHSR1a:DRD1 heteromers in brain slices were detected by
FRET microscopy using Olympus FluoView 1000 (see Supplemental Experi-
mental Procedures for more details).D1 Interactions
agonist (left). DRD1 agonist treatment interferes with PPI inGhsr +/+mice, but
at is blocked by coinfusion of JMV2959 (JMV); (7–10 animals per group).
KF) into the DG enhances of working memory that is blocked by coinfusion of
Immunofluorescence Microscopy of Mouse Brain Sections and
Organotypic Brain Slices
GHSR1a and DRD1 immunofluorescence was performed on brain sections
from adult male Ghsr-IRES-tauGFP mice as described previously (Kern
et al., 2012) with modifications.
After treatments, organotypic brain slices were processed for immunofluo-
rescence staining. Seemoredetails inSupplemental ExperimentalProcedures.
Ribosome Immunoprecipitation, Purification of mRNA, and qPCR
Ribosomal pS6 immunoprecipitation, mRNA purification, and qRT-PCR was
performed on hippocampal organotypic slices as previously described (Knight
et al., 2012) (see Supplemental Experimental Procedures for more details).
Behavioral Tests
PPI was performed as described previously (Geyer and Dulawa, 2003), CFC
was performed as described (Fiorenza et al., 2012), and the delayed alterna-
tion T-maze task was performed as described (Deacon and Rawlins, 2006);
all the above tests were performed with modifications (see Supplemental
Experimental Procedures for more details).
Data Analysis
Values are given as means ± SEM and obtained from the number of separate
experiments indicated. Comparisons between the different groups were made
using Student’s t test or one-way ANOVA test. Data were analyzed using
GraphPad Instat software, and a difference of p < 0.05 was considered
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2015.10.062.
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